News
Changing the Future of Mobility: Advanced Transportation Innovation
1/15/2016Research partnerships and innovations from the University of Michigan and our industry partners are creating exciting advances in automobile and other forms of transportation. U-M researchers are key contributors in many areas, including electrification technologies, digital solutions (connected vehicles and mobility), advanced materials (safety and improved fuel economy) and energy...
Menin-MLL Inhibitors: A Potential Treatment for a Rare and Deadly Leukemia
1/15/2016Oncology researchers Jolanta Grembecka and Tomasz Cierpicki began what they refer to as their “adventures in drug discovery” at the University of Virginia, where they focused on treatments for leukemia-related diseases. Their ultimate goal has always been to create new small molecules for protein targets neglected by industry—what are known...
The Neuroma Surgical Tool: Advancing Treatments for Amputees
1/13/2016Each year, approximately 185,000 amputations are performed in this country. One of the biggest challenges facing amputees is constant, severe pain caused by neuromas—balls of raw nerve fiber that grow at the end of severed nerves. Research conducted by U-M Professor of Plastic Surgery Paul Cederna demonstrated that this pain...
GENOMENON: Empowering Personalized Medicine
1/13/2016Genome sequencing has revolutionized the health care field, opening the way to a new era of personalized medicine. It is now possible to sequence the entire human genome—all 3 billion letters of information— in about a day. But analyzing and interpreting the data is a slow, error-prone process that can...
U-M cybersecurity startup QuadMetrics calculates odds a company will be breached
1/12/2016QuadMetrics Inc. says it can predict with greater than 90% accuracy the likelihood that a company will be breached within the next year…
J&J announces collaboration with U-M startup HistoSonics for non-invasive solid tumor treatment
1/11/2016Although surgical resection remains the gold standard treatment for solid tumors, approximately 85 percent of patients are not candidates for surgical resection, particularly those with cancers of the liver and pancreas. Ethicon Endo-Surgery, Inc. has entered into a collaboration with HistoSonics, a company developing histotripsy, a non-invasive soft tissue ablation...
Rapid Oxygen seeks to bring new emergency oxygen system to market
1/11/2016Rapid Oxygen Company wants to breathe fresh air into the stale medical oxygen systems market using technology from the University of Michigan Department of Emergency Medicine. Current supplemental oxygen systems use portable concentrators, high pressure gas cylinders, or chemical generators – technology largely unchanged since the 1940s. These “state-of-the-art” systems...
U-M startup Millendo announces $62M Series B to pursue endocrine disorder therapies
1/5/2016What started as research into one of the most rare types of cancer has expanded into a portfolio that includes a potential treatment for the most common endocrine disease in women…
ViewPoint Therapeutics signs license with U-M for potential cataract treatment
12/17/2015A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from the University of Michigan (U-M), UC San Francisco (UCSF) and Washington University in St. Louis (WUSTL)…
Materialise and U-M startup TRS announce partnership to manufacture 3D-printed tracheal splints
12/9/2015Today, Materialise (NASDAQ: MTLS) and Tissue Regeneration Systems (TRS) announce a partnership to manufacture life-saving 3D-Printed tracheal splints for use in clinical trials…
Sony launches connected tennis racket with U-M tech
12/8/2015Just months after Wilson Sporting Goods launched its Wilson X Connected Basketball employing patented technology from the University of Michigan lab of Noel Perkins, Sony, through a sub-license with Wilson, has come to market with a smart tennis sensor based on the same underlying U-M technology. The sensor, when affixed...
U-M and Belgium company Materialise sign license agreement for life-saving 3D-printed tracheal splints
12/7/2015A new agreement opens the door for groundbreaking, 3D-printed technology that saved four babies’ lives to help more children at C.S. Mott Children’s Hospital. The University of Michigan and Belgium-based Materialise, which has a Plymouth branch, signed a license agreement on Thursday that will ultimately commercialize the 3D printed splints...